Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.

Pfaar O, Bachert C, Kuna P, Panzner P, Džupinová M, Klimek L, van Nimwegen MJ, Boot JD, Yu D, Opstelten DJE, de Kam PJ.

J Allergy Clin Immunol. 2019 Mar;143(3):970-977. doi: 10.1016/j.jaci.2018.11.018. Epub 2018 Nov 30.

2.

Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.

van Miltenburg MH, van Nimwegen MJ, Tijdens I, Lalai R, Kuiper R, Klarenbeek S, Schouten PC, de Vries A, Jonkers J, van de Water B.

Br J Cancer. 2014 May 27;110(11):2747-55. doi: 10.1038/bjc.2014.219. Epub 2014 May 8.

3.

An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis.

van Nimwegen MJ, Verkoeijen S, Kuppen PJ, Velthuis JH, van de Water B.

Clin Exp Metastasis. 2007;24(5):379-87. Epub 2007 May 31.

PMID:
17541710
4.

Focal adhesion kinase: a potential target in cancer therapy.

van Nimwegen MJ, van de Water B.

Biochem Pharmacol. 2007 Mar 1;73(5):597-609. Epub 2006 Sep 25. Review.

PMID:
16997283
5.

Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells.

van Nimwegen MJ, Huigsloot M, Camier A, Tijdens IB, van de Water B.

Mol Pharmacol. 2006 Oct;70(4):1330-9. Epub 2006 Jul 6.

PMID:
16825486
6.

Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.

van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B.

Cancer Res. 2005 Jun 1;65(11):4698-706.

Supplemental Content

Loading ...
Support Center